| Amgen Switzerland AG - Aranesp 50 Mikrogramm, Injektionslösung in Fertigspritze |
| 55725 | | 06 | | Aranesp 50 Mikrogramm | | Injektionslösung in Fertigspritze | | B03XA02 | | Darbepoetin Alfa | | 13.09.2002 | | |
|
| Composition |
| darbepoetinum alfa 50 µg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp., natrium 1.89 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Darbepoetin Alfa | 50µg / 0.5ml |
| | BAG: Active Agent | Dose |
|---|
| Darbepoetin Alfa | 0.05 mg |
| | | | Inactive agents |
|---|
| Disodium Phosphate | | Sodium Chloride | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 061 | syringe(s) | PR | PR | A | | Yes | | 062 | 4 syringe(s) | 422.82 | 476.25 | A | SL | Yes |
|
